HEIDI CRULL: Open Payments
NPI 1013281427 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,066 in 94 payments from 19 companies in 2025. Trend: 2023 $2,381 · 2024 $2,832 · 2025 $2,066
Food & beverage: $2,066
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $504 |
| ABBVIE INC. | 15 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $212 |
| Madrigal Pharmaceuticals | 6 | $184 |
| Ipsen Biopharmaceuticals, Inc | 7 | $153 |
| Lilly USA, LLC | 9 | $152 |
| Gilead Sciences, Inc. | 7 | $146 |
| PFIZER INC. | 5 | $85 |
| GENZYME CORPORATION | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
Products named: TREMFYA, REZDIFFRA, IQIRVO, OMVOH, ENTYVIO, RINVOQ, DUPIXENT, VIBERZI.
Industry payments across MO — which companies pay providers there.
